Signs of success have been noted by a new gene therapy that engineer's an individual's T cells such that it becomes resistant to HIV, researchers claim. Also called gene editing, the process acts like molecular scissors to snip off an entry portal for HIV so the virus cannot enter these key immune cells. Once the cells lack the CCR5 protein, the immune system behaves much the way it does in a rare set of people -- about one percent of the population ...
Read More
No comments:
Post a Comment